January 5, 2012 – NinePoint Medical Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Nvision VLE Imaging System, a next-generation, high-resolution optical imaging technology. The Nvision VLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional and real-time depth visualization.

The Nvision VLE Imaging System is the first volumetric optical coherence tomography (OCT) device cleared by the FDA for endoscopic imaging. It uses a circumferential scanning technique and an automatic pullback to generate cross sectional and longitudinal images simultaneously in real-time. Clinicians can then analyze and immediately act on these images, thus providing patients with streamlined care and a significantly shortened timeline between detection, diagnosis and treatment.

The Nvision VLE Imaging System:

  • Is the only technology that can generate a volumetric image of the target organ in real-time that can be viewed simultaneously in cross-section and longitudinal vizualization.
  • Utilizes a high-resolution display and proprietary software to provide an image that can be reviewed to identify areas of suspicion such as inflammatory, metaplastic or dysplastic changes, or possible cancers.
  • Can image beneath the mucosal surface at less than 10 micron resolution up to a tissue depth of 3 mm, unlike white light endoscopy, which can only image surface detail. This also compares favorably to confocal microscopy, which only has up to 250-500 microns depth of penetration.
  • Offers a full field, circumferential view, compared with confocal microscopy, which only offers a 0.5 x 0.5 mm segment of tissue view.
  • Can image circumferentially or helically up to 6cm in length in less than 100 seconds.  

“We will be conducting clinical trials of the Nvision VLE Imaging System in 2012 and will be scaling up our manufacturing capabilities to support a commercial launch in 2013,” said Charles Carignan, M.D., president and chief executive officer of NinePoint Medical.  “We believe our technology can improve patient outcomes, shorten the timeframes associated with diagnostic and treatment procedures and significantly reduce health care system costs.”

In 2010, NinePoint Medical entered into an intellectual property licensing agreement with Massachusetts General Hospital (MGH) supporting the development of the Nvision VLE Imaging System. Under the agreement, NinePoint obtained certain exclusive rights in multiple fields to 188 patents and patent applications owned by MGH.  

For more information: www.ninepointmedical.com

 

Related Content

News | Endoscopes

December 23, 2019 — The U.S. Food and Drug Administration cleared for marketing in the U.S. the first fully disposable ...

Time December 23, 2019
arrow
News | Endoscopes

December 23, 2019 — Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Time December 23, 2019
arrow
News | Endoscopes

October 22, 2019 — OmniVision Technologies Inc. announced that its OV6948 camera module is the winner of the Guinness ...

Time October 22, 2019
arrow
News | Endoscopes

Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. Obstetricians and gynecologists (ObGyns) can use the new Omni hysteroscope in out- and inpatient settings.

Time March 14, 2019
arrow
Videos | Advanced Visualization

This is an example of a new endoscopic virtual peritoneal inflation tool on the patient's computed tomography (CT) ...

Time March 05, 2019
arrow
Videos | Advanced Visualization

This is an example of a new endoscopic 3-D imaging simulator created from a patient's computed tomography (CT) scan ...

Time March 05, 2019
arrow
Technology | Advanced Visualization

Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla. The latest Synapse 3D Advanced Visualization software introduces five new applications, in addition to its current 50 clinical applications, that will be available for demonstration.

Time February 08, 2019
arrow
Technology | Lung Imaging

Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its LungVision platform. The platform will be presented at the CHEST conference, Oct. 7-10 in San Antonio, Texas.

Time October 05, 2018
arrow
News | Endoscopes

During the 2018 Digestive Disease Week (DDW) conference June 2-5 in Washington, D.C., the American Society for Gastrointestinal Endoscopy (ASGE), in collaboration with Touch Surgery, demonstrated three mobile-accessed and video-based simulations at ASGE’s Learning Center. Working closely with ASGE, Touch Surgery was able to convert endoscopic procedural videos into interactive mini-simulations.

Time June 11, 2018
arrow
News | Ultrasound Imaging

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures ...

Time June 04, 2018
arrow
Subscribe Now